MOXONIDINE TREATMENT AND METFORMIN METABOLIC SYNDROME

The given researches about true prevalence of basic components of МS can form base for working out and realization of treatment-and-prophylactic programs on revealing and treatment МS. Application of factors of a glycemia is the important help in revealing of risk of formation of components of МS at persons with normal levels of a glycemia. The taped differences of efficiency of Moksonidinum and Metforminum on various phases glycaemic a curve allow to spend the differentiated therapy by these preparations depending on presence at the patient of disturbance of different phases glycaemic a curve.